NASDAQ:XERS | Operating Income | Xeris Biopharma Holdings, Inc.

Complete source-backed operating income history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30$5.17M
2026-03-31$7.92M
2025-12-31$16.77M
2025-09-30$6.73M
2025-06-30$4.48M
2025-03-31-$3.09M
2024-12-31$1.68M
2024-09-30-$12.89M
2024-06-30-$8.19M
2024-03-31-$14.25M
2023-12-31-$9.84M
2023-09-30-$4.91M
2023-06-30-$15.98M
2023-03-31-$13.28M
2022-12-31-$15.17M
2022-09-30-$18.78M
2022-06-30-$18.92M
2022-03-31-$29.07M
2021-12-31-$48.27M
2021-09-30-$24.36M
2021-06-30-$25.79M
2021-03-31-$16.74M
2020-12-31-$19.34M
2020-09-30-$13.74M

Annual Operating Income

DateOperating Income
2025-12-31$24.9M
2024-12-31-$33.65M
2023-12-31-$44.01M
2022-12-31-$81.94M
2021-12-31-$115.16M
2020-12-31-$83.55M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.